Transwell cell migration and invasion assays showed that CRIP1 overexpression promoted GC cell motility and invasiveness, whereas CRIP1 knockdown inhibited these effects (Figure S4A–D, Supporting Information). The gene discussed is CRIP1; the disease is gastric cancer.